PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure.
Elena PiccininSimon DucheixClaudia PeresMaria ArconzoMaria Carmela VeglianteFerretta AnnaElena BellafanteGaetano VillaniAntonio MoschettaPublished in: Scientific reports (2019)
Acetaminophen (APAP) is a worldwide commonly used painkiller drug. However, high doses of APAP can lead to acute hepatic failure and, in some cases, death. Previous studies indicated that different factors, including life-style and metabolic diseases, could predispose to the risk of APAP-induced liver failure. However, the molecular process that could favor APAP hepatotoxicity remains understood. Here, we reported that a short-term high fat-enriched diet worsens APAP-induced liver damage, by promoting liver accumulation of lipids that induces the activation of peroxisome proliferator-activated receptor gamma coactivator 1-beta (PGC-1β). Therefore, we challenged mice with hepatic-specific PGC-1β overexpression on a chow diet with a subtoxic dose of APAP and we found that PGC-1β overexpression renders the liver more sensitive to APAP damage, mainly due to intense oxidative stress, finally ending up with liver necrosis and mice death. Overall, our results indicated that during high fat feeding, PGC-1β adversely influences the ability of the liver to overcome APAP toxicity by orchestrating different metabolic pathways that finally lead to fatal outcome.
Keyphrases
- liver failure
- oxidative stress
- hepatitis b virus
- skeletal muscle
- drug induced
- liver injury
- diabetic rats
- high glucose
- physical activity
- weight loss
- transcription factor
- intensive care unit
- respiratory failure
- single molecule
- metabolic syndrome
- binding protein
- endothelial cells
- induced apoptosis
- electronic health record
- mechanical ventilation
- endoplasmic reticulum stress